Literature DB >> 7758173

Apoptosis in human atherosclerosis and restenosis.

J M Isner1, M Kearney, S Bortman, J Passeri.   

Abstract

BACKGROUND: Apoptosis has been recognized in normal, including rapidly proliferating, cell populations and is inferred to be potentially responsible for the maintenance of stable cell numbers in tissues with various degrees of proliferative activity. Previous studies performed in rats indicated that despite the persistence of a relatively high level of injury-induced proliferative activity, total arterial smooth muscle content at 12 weeks remained unchanged from that measured at 2 weeks, suggesting that accrual of vascular smooth muscle cells is mitigated by cell death. The extent to which apoptosis may be observed in human atherosclerosis and/or restenosis, however, has not been previously established. METHODS AND
RESULTS: We performed immunohistochemical studies on 56 specimens retrieved from patients undergoing directional atherectomy for primary atherosclerotic lesions or recurrent arterial narrowing after percutaneous revascularization (restenosis). Immunohistochemical staining disclosed evidence of apoptosis in 35 (63%) of the 56 specimens studied. When present, immunohistochemical evidence of apoptosis was typically limited to < 2% of cells in the specimen. The finding of apoptosis, however, was not distributed equally among four groups of specimens studied. Specimens retrieved from patients with restenosis were more frequently observed to contain foci of apoptosis than specimens retrieved from patients with primary atherosclerotic lesions. Among 14 peripheral arterial specimens from patients with restenosis, 13 (93%) contained foci of apoptosis; in contrast, apoptosis was observed in only 6 (43%) of 14 peripheral specimens from patients with primary lesions (P = .0046). Among coronary arterial specimens, apoptosis was observed in 12 (86%) of 14 specimens from patients with restenosis versus 6 (29%) of 14 specimens from patients with primary obstructions (P < .0075).
CONCLUSIONS: Apoptosis is a feature of human vascular pathology, including restenotic lesions and, to a lesser extent, primary atherosclerotic lesions. The findings of the present study suggest that apoptosis may modulate the cellularity of lesions that produce human vascular obstruction, particularly those with evidence of more extensive proliferative activity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7758173     DOI: 10.1161/01.cir.91.11.2703

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  80 in total

Review 1.  Vascular smooth muscle cell apoptosis in atherosclerosis.

Authors:  J J Boyle
Journal:  Int J Exp Pathol       Date:  1999-08       Impact factor: 1.925

Review 2.  Early and late effects of radiation treatment for prevention of coronary restenosis: a critical appraisal.

Authors:  O F Bertrand; S Lehnert; R Mongrain; M G Bourassa
Journal:  Heart       Date:  1999-12       Impact factor: 5.994

3.  Dynamics of Vascular Remodeling: An Overview and Bibliography.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1996       Impact factor: 2.300

4.  Localization of apoptotic macrophages at the site of plaque rupture in sudden coronary death.

Authors:  F D Kolodgie; J Narula; A P Burke; N Haider; A Farb; Y Hui-Liang; J Smialek; R Virmani
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

Review 5.  New insights into atherosclerotic plaque rupture.

Authors:  D M Braganza; M R Bennett
Journal:  Postgrad Med J       Date:  2001-02       Impact factor: 2.401

Review 6.  Gene therapy for restenosis.

Authors:  R C Smith; K Walsh
Journal:  Curr Cardiol Rep       Date:  2000-01       Impact factor: 2.931

7.  Vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in normal and atherosclerotic human arteries.

Authors:  T Couffinhal; M Kearney; B Witzenbichler; D Chen; T Murohara; D W Losordo; J Symes; J M Isner
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

8.  Neointimal tissue characteristics following sirolimus-eluting stent implantation: OCT quantitative tissue property analysis.

Authors:  Jingbo Hou; Haibo Jia; Haixia Liu; Zhigang Han; Shuang Yang; Chenyang Xu; Joseph Schmitt; Shaosong Zhang; Bo Yu; Ik-Kyung Jang
Journal:  Int J Cardiovasc Imaging       Date:  2012-03-16       Impact factor: 2.357

9.  Novel small leucine-rich repeat protein podocan is a negative regulator of migration and proliferation of smooth muscle cells, modulates neointima formation, and is expressed in human atheroma.

Authors:  Randolph Hutter; Li Huang; Walter S Speidl; Chiara Giannarelli; Paul Trubin; Gerhard Bauriedel; Mary E Klotman; Valentin Fuster; Juan J Badimon; Paul E Klotman
Journal:  Circulation       Date:  2013-09-16       Impact factor: 29.690

10.  Acute myocardial infarction caused by thrombotic occlusion at a stent site two years after conventional stent implantation.

Authors:  T Hayashi; A Kimura; K Ishikawa
Journal:  Heart       Date:  2004-05       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.